-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $16

Benzinga·11/20/2026 17:53:45
Listen to the news
Craig-Hallum analyst Adam Vogel initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $16.